Resmed (RMD) Enterprise Value (2009 - 2026)

Resmed's Enterprise Value history runs 18 years deep, the most recent figure standing at -$1.7 billion for Q1 2026.

• Quarterly Enterprise Value fell 78.03% year-over-year to -$1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 billion (down 78.03% YoY) and the FY2025 annual result came in at -$1.2 billion, down 407.4% from the prior year.
• Enterprise Value was -$1.7 billion for Q1 2026 at Resmed, down from -$1.4 billion in the prior quarter.
• Across five years, Enterprise Value topped out at -$201.8 million in Q1 2022 and bottomed at -$1.7 billion in Q1 2026.
• A 5-year average of -$578.8 million and a median of -$253.2 million in 2022 frame the typical range for Enterprise Value.
• Annual changes were most pronounced in 2022 — Enterprise Value rose 24.98% — and 2025, when it tumbled 407.4%.
• Resmed's Enterprise Value stood at -$253.2 million in 2022, then rose by 16.96% to -$210.2 million in 2023, then slumped by 148.25% to -$521.9 million in 2024, then tumbled by 171.5% to -$1.4 billion in 2025, then retreated by 17.18% to -$1.7 billion in 2026.
• Business Quant data shows RMD's Enterprise Value at -$1.7 billion in Q1 2026, -$1.4 billion in Q4 2025, and -$1.4 billion in Q3 2025.